Clinical Tools and Diagnostic Companies:Financial Metrics 2014 Q1Results
Clinical Diagnostic Stocks Were Hit By Bio-Bubble or Revenue Miss Potential upside in EXAS, NSTG and NEOG all are Rayno Dx and Tools picks. With "momentum trading" days over for now, revenue growth is the focus. Companies with disappointing Q1 revenues: Abaxis (ABAX), Alere (ALR), Response...
ASCO Update #4- No Boost For Oncology Stocks… Update-6/4 MDVN, PCYC, SGEN
Update 6/4 Snap- back rally and big green screen! Update 6/3..... Daily Performance-from list below 9 winners, 12 losers Rayno Biopharmaceutical Picks in bold--- Winners: AGIO, INCY, SGEN, EPZM, MDVN, IMGN, GILD. CELG, PCYC. Losers: CLVS, ARIA, NLNK,CLDX, BLUE, LBIO, PBYI, KPTI, BMY, AZN,...
Rayno Dx and Tools 2014 YTD After OCT. Correction: ABAX EXAS ILMN SQNM …Update 12/24/14
Update 11/24/14 Clinical Diagnostics and Tools Stocks Review Performance YTD and compared to 11/13 YTD Top winners YTD are: EXAS 104%, ILMN 71.4%, ABAX 36.8% Top Losers YTD are: NSTG 16.6%, RGDX 54%, VRML 30.9% but all were good trades. IWM at $117.4 See Performance Data Below...
Very Little Bounce in Biotech as ASCO Approaches… Update 2.. 5/22
Rally Developing-Green Screen Alert If you are underweight large cap biotech add FBT ($76.38) up 2%. Most of our large cap picks are up today: ABBV ALXN, BIIB,GILD,REGN. Reverse pattern from tuesday's downdraft. -------------- One of the worse days I have seen in small cap biotech in many...
Pre-ASCO Watch List #2: ARIA, IMGN, PCYC
Rayno Life Science Focus Stocks: ARIA, IMGN, PCYC Ariad (ARIA) Abstracts Several data presentations will be made for Iclusig (Ponatinib) for leukemias and AP26113 its investigational oral inhibitor of anaplastic lymphoma kinase (ALK). A breakfast meeting featuring key investigators and slide...